Sphera Funds Management Ltd. Lava Therapeutics Nv Transaction History

Sphera Funds Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.91 - $1.44 $70,896 - $112,187	-77,908 Reduced 61.67%	48,420 $61,000
Q4 2024 Feb 14, 2025	SELL	$0.98 - $2.04 $19,726 - $41,063	-20,129 Reduced 13.74%	126,328 $123,000
Q3 2024 Nov 14, 2024	SELL	$1.57 - $2.29 $347,166 - $506,376	-221,125 Reduced 60.16%	146,457 $243,000
Q1 2024 May 15, 2024	BUY	$1.53 - $4.03 $562,400 - $1.48 Million	367,582 New	367,582 $1.22 Million
Q1 2022 May 16, 2022	SELL	$4.28 - $6.55 $590,027 - $902,963	-137,857 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.23 - $7.77 $327,833 - $602,190	-77,502 Reduced 35.99%	137,857 $758,000
Q2 2021 Aug 17, 2021	BUY	$10.8 - $16.0 $15,822 - $23,440	1,465 Added 0.68%	215,359 $2.34 Million
Q1 2021 May 17, 2021	BUY	$12.5 - $15.19 $2.67 Million - $3.25 Million	213,894 New	213,894 $3.25 Million

4.94M

17.9K

200

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $39.5M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.